Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can treatment with risedronate benefit patients with knee osteoarthritis?

Nature Clinical Practice Rheumatology volume 3, pages 198–199 (2007)Cite this article

boxed-textBingham CO et al. (2006) Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee. Results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 54: 3494–3507

Bisphosphonates do not alleviate symptoms or slow the rate of disease progression in patients with knee OA

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Garnero P (2006) Biochemical markers in osteoarthritis: will they measure up? Nat Clin Pract Rheumatol 2: 116–117

    Article  CAS  Google Scholar 

  2. Lohmander LS and Eyre DR (2005) From biomarker to surrogate outcome in osteoarthritis—what are the challenges? J Rheumatol 32: 1142–1143

    PubMed  Google Scholar 

  3. Mazzuca SA et al. (2006) Urinary levels of type II collagen C–telopeptide crosslink are unrelated to joint space narrowing in patients with knee osteoarthritis. Ann Rheum Dis 65: 1055–1059

    Article  CAS  Google Scholar 

  4. Mitchell PG et al. (2006) Pharmacodynamic modulation of bone-derived and cartilage-derived collagen biomarkers in the ovarectomized rat model. Osteoarthr Cartil 14 [suppl B]: S60

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Orthopaedics, Clinical Sciences Lund, Lund University, Lund University Hospital, SE-22185 Lund, Sweden stefan.lohmander@med.lu.se

Authors and Affiliations

  1. S Lohmander is a Professor and Senior Consultant of Orthopaedics in the Department of Clinical Sciences at Lund University, Lund, Sweden.,

    Stefan Lohmander

Authors
  1. Stefan Lohmander
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lohmander, S. Can treatment with risedronate benefit patients with knee osteoarthritis?. Nat Rev Rheumatol 3, 198–199 (2007). https://doi.org/10.1038/ncprheum0456

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0456

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing